The global bio-imaging market has a tremendous potential to grow over the coming years as this technology may evolve as a pillar for diagnosis, which is expected to give rise to numerous innovations and business opportunities. The bioimaging techniques are regarded as promising advancements in the field of healthcare and biomedical research. These reforms are projected to foster the evolution of cost-effective, compact, portable and simple devices. With the drastic development in cell biology, biochemistry and computer analysis used for molecular imaging technologies is set to increase over the next seven years exponentially.
A full report of Bio-imaging Market available at https://www.orionmarketreports.com/tv-analytics-market/41370/
The key participants in this industry are Bracco Imaging S.P.A, Bayer HealthCare Pharmaceuticals, Esaote S.p.A, Digirad Corporation, FONAR Corporation, GE Healthcare, Hologic Inc, Hitachi Medical Corporation, Lantheus Medical Imaging, Inc., Covidien Pharmaceuticals, Mindray Medical International Limited.
Bio-imaging Market: Segmentation
By Type
Medical Bio-Imaging
• MRI (Magnetic Resonance Imaging)
• PET-CT
• Ultrasound
• Radiological Imaging
• Optical Imaging
Molecular Bio-Imaging
• Nano Bio-Imaging
Biomarkers
• Molecular Probes
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
